Table 2.
Clinical indexes changes between groups after treatment period
| Control group (n = 81) | DF group (n = 81) | p value | |
|---|---|---|---|
| Hb [(g/L, M (IQR)] | 94.00 (14.50) | 117.00 (12.50) | < 0.0001 |
| Fe2+ [μmol/L,M (IQR)] | 10.26 (5.55) | 13.23 (4.83) | < 0.0001 |
| SF [ng/mL, M (IQR)] | 41.48 (36.60) | 54.15 (86.66) | 0.003 |
| sTfR [(g/L), M (IQR)] | 1.65 (0.75) | 1.65 (0.88) | 0.572 |
| hepcidin [(pg/mL), M (IQR)] | 58.85 (42.55) | 58.11 (39.38) | 0.988 |
| rhEPO [IU/W, M (IQR)] | 15,000.00 (6000.00) | 12,000.00 (7000.00) | 0.122 |
sTfR soluble transferrin receptor, Hb hemoglobin, Fe2+ serum iron, SF serum ferritin, rhEPO recombinant human erythropoietin, IU/W international unit per week, DF dietary fiber